Insulet Corporation (PODD)
USD 256.8
(-4.58%)
USD 256.8
(-4.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 220 Million USD | 923.97% |
| 2022 | -26.7 Million USD | -140.03% |
| 2021 | 66.7 Million USD | 11216.67% |
| 2020 | -600 Thousand USD | -102.71% |
| 2019 | 22.1 Million USD | -19.41% |
| 2018 | 27.42 Million USD | 471.23% |
| 2017 | -7.38 Million USD | 30.99% |
| 2016 | -10.7 Million USD | 78.04% |
| 2015 | -48.73 Million USD | -296.32% |
| 2014 | -12.29 Million USD | 57.79% |
| 2013 | -29.13 Million USD | 19.0% |
| 2012 | -35.97 Million USD | 15.3% |
| 2011 | -42.46 Million USD | -9.92% |
| 2010 | -38.63 Million USD | 34.92% |
| 2009 | -59.35 Million USD | 33.56% |
| 2008 | -89.34 Million USD | -65.93% |
| 2007 | -53.84 Million USD | -55.41% |
| 2006 | -34.64 Million USD | -61.1% |
| 2005 | -21.5 Million USD | -51.95% |
| 2004 | -14.15 Million USD | -17.8% |
| 2003 | -12.01 Million USD | 5.19% |
| 2002 | -12.67 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 56.9 Million USD | -54.04% |
| 2024 Q2 | 54.6 Million USD | -4.04% |
| 2023 FY | 220 Million USD | 923.97% |
| 2023 Q4 | 123.8 Million USD | 125.91% |
| 2023 Q3 | 54.8 Million USD | 76.21% |
| 2023 Q1 | 10.3 Million USD | 17.05% |
| 2023 Q2 | 31.1 Million USD | 201.94% |
| 2022 Q1 | 22.9 Million USD | -53.92% |
| 2022 Q2 | -26.7 Million USD | -216.59% |
| 2022 Q3 | -14.8 Million USD | 44.57% |
| 2022 Q4 | 8.8 Million USD | 159.46% |
| 2022 FY | -26.7 Million USD | -140.03% |
| 2021 Q2 | 26.3 Million USD | 61.35% |
| 2021 FY | 66.7 Million USD | 11216.67% |
| 2021 Q4 | 49.7 Million USD | 47.48% |
| 2021 Q1 | 16.3 Million USD | 323.29% |
| 2021 Q3 | 33.7 Million USD | 28.14% |
| 2020 Q3 | 23.8 Million USD | -13.45% |
| 2020 Q2 | 27.5 Million USD | 266.67% |
| 2020 Q1 | 7.5 Million USD | -58.79% |
| 2020 FY | -600 Thousand USD | -102.71% |
| 2020 Q4 | -7.3 Million USD | -130.67% |
| 2019 FY | 22.1 Million USD | -19.41% |
| 2019 Q1 | 7.26 Million USD | -55.25% |
| 2019 Q2 | 7.6 Million USD | 4.65% |
| 2019 Q3 | 17 Million USD | 123.65% |
| 2019 Q4 | 18.2 Million USD | 7.03% |
| 2018 Q1 | 1.68 Million USD | 319.01% |
| 2018 Q2 | 4.32 Million USD | 157.13% |
| 2018 Q3 | 6.86 Million USD | 58.73% |
| 2018 FY | 27.42 Million USD | 471.23% |
| 2018 Q4 | 16.23 Million USD | 136.46% |
| 2017 Q1 | -5.3 Million USD | -28.37% |
| 2017 FY | -7.38 Million USD | 30.99% |
| 2017 Q4 | -768 Thousand USD | -137.52% |
| 2017 Q3 | 2.04 Million USD | 160.96% |
| 2017 Q2 | -3.35 Million USD | 36.74% |
| 2016 Q2 | -1.28 Million USD | 83.27% |
| 2016 Q1 | -7.69 Million USD | 67.97% |
| 2016 Q4 | -4.13 Million USD | -271.01% |
| 2016 FY | -10.7 Million USD | 78.04% |
| 2016 Q3 | 2.41 Million USD | 287.73% |
| 2015 Q3 | -15.73 Million USD | -27.29% |
| 2015 Q1 | -8.63 Million USD | -282.71% |
| 2015 FY | -48.73 Million USD | -296.32% |
| 2015 Q4 | -24.04 Million USD | -52.79% |
| 2015 Q2 | -12.36 Million USD | -43.23% |
| 2014 FY | -12.29 Million USD | 57.79% |
| 2014 Q4 | -2.25 Million USD | 21.59% |
| 2014 Q1 | -1.88 Million USD | -1015.53% |
| 2014 Q2 | -5.28 Million USD | -179.96% |
| 2014 Q3 | -2.87 Million USD | 45.53% |
| 2013 Q2 | -5.82 Million USD | 6.19% |
| 2013 FY | -29.13 Million USD | 19.0% |
| 2013 Q4 | 206 Thousand USD | 101.19% |
| 2013 Q3 | -17.31 Million USD | -197.37% |
| 2013 Q1 | -6.2 Million USD | -1.97% |
| 2012 Q4 | -6.08 Million USD | 28.15% |
| 2012 Q1 | -10.89 Million USD | -3.64% |
| 2012 Q3 | -8.47 Million USD | 19.47% |
| 2012 Q2 | -10.51 Million USD | 3.45% |
| 2012 FY | -35.97 Million USD | 15.3% |
| 2011 Q2 | -14.91 Million USD | -105.07% |
| 2011 Q4 | -10.51 Million USD | -7.62% |
| 2011 Q3 | -9.76 Million USD | 34.51% |
| 2011 Q1 | -7.27 Million USD | 25.21% |
| 2011 FY | -42.46 Million USD | -9.92% |
| 2010 Q1 | -10.73 Million USD | 10.3% |
| 2010 Q3 | -8.27 Million USD | 16.38% |
| 2010 Q2 | -9.9 Million USD | 7.74% |
| 2010 Q4 | -9.72 Million USD | -17.48% |
| 2010 FY | -38.63 Million USD | 34.92% |
| 2009 Q4 | -11.96 Million USD | 11.26% |
| 2009 FY | -59.35 Million USD | 33.56% |
| 2009 Q3 | -13.48 Million USD | 18.03% |
| 2009 Q2 | -16.44 Million USD | 5.88% |
| 2009 Q1 | -17.47 Million USD | 36.13% |
| 2008 Q4 | -27.35 Million USD | -37.92% |
| 2008 FY | -89.34 Million USD | -65.93% |
| 2008 Q1 | -20.01 Million USD | -24.65% |
| 2008 Q2 | -22.13 Million USD | -10.63% |
| 2008 Q3 | -19.83 Million USD | 10.41% |
| 2007 Q1 | -10.79 Million USD | -17.4% |
| 2007 Q4 | -16.05 Million USD | -10.09% |
| 2007 FY | -53.84 Million USD | -55.41% |
| 2007 Q3 | -14.58 Million USD | -17.51% |
| 2007 Q2 | -12.4 Million USD | -14.92% |
| 2006 FY | -34.64 Million USD | -61.1% |
| 2006 Q2 | 674 Thousand USD | 0.0% |
| 2006 Q1 | 674 Thousand USD | 110.35% |
| 2006 Q3 | -8.48 Million USD | -1358.46% |
| 2006 Q4 | -9.19 Million USD | -8.44% |
| 2005 Q3 | -5.04 Million USD | 0.0% |
| 2005 Q1 | -5.04 Million USD | 0.0% |
| 2005 Q2 | -5.04 Million USD | 0.0% |
| 2005 FY | -21.5 Million USD | -51.95% |
| 2005 Q4 | -6.51 Million USD | -29.22% |
| 2004 FY | -14.15 Million USD | -17.8% |
| 2003 FY | -12.01 Million USD | 5.19% |
| 2002 FY | -12.67 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 1631.927% |
| Cerus Corporation | -30.05 Million USD | 832.04% |
| OrthoPediatrics Corp. | -25.76 Million USD | 953.838% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 2171.302% |
| Talis Biomedical Corporation | -66.81 Million USD | 429.267% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 1371.97% |
| Inogen, Inc. | -109.38 Million USD | 301.123% |
| Spectral AI, Inc. | -12.98 Million USD | 1794.393% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 451.499% |
| CVRx, Inc. | -43.1 Million USD | 610.405% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 6335.828% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 1870.196% |
| Orthofix Medical Inc. | -139.11 Million USD | 258.148% |
| Venus Concept Inc. | -28.3 Million USD | 877.138% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 507.196% |
| Bioventus Inc. | -81.72 Million USD | 369.195% |
| BrainsWay Ltd. | -4.92 Million USD | 4565.192% |
| Envoy Medical, Inc. | -18.37 Million USD | 1297.54% |
| electroCore, Inc. | -18.8 Million USD | 1269.902% |
| IceCure Medical Ltd | -15.57 Million USD | 1512.429% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 553.777% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 1374.031% |
| MaxCyte, Inc. | -48.29 Million USD | 555.496% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 1940.196% |
| Nexalin Technology, Inc. | -5.69 Million USD | 3962.159% |
| PAVmed Inc | -68.79 Million USD | 419.791% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 488.947% |
| RxSight, Inc. | -50.08 Million USD | 539.253% |
| Sight Sciences, Inc. | -57.27 Million USD | 484.118% |
| SI-BONE, Inc. | -46.93 Million USD | 568.773% |
| TELA Bio, Inc. | -44.07 Million USD | 599.149% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 506.279% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 527.783% |
| LivaNova PLC | -68.49 Million USD | 421.177% |
| 908 Devices Inc. | -42.75 Million USD | 614.524% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 226.878% |
| Nemaura Medical Inc. | -9.59 Million USD | 2392.805% |
| NeuroPace, Inc. | -27.17 Million USD | 909.597% |
| LENSAR, Inc. | -12.22 Million USD | 1899.002% |
| Apyx Medical Corporation | -17.25 Million USD | 1374.697% |
| Cutera, Inc. | -156.23 Million USD | 240.818% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 2656.95% |
| BioSig Technologies, Inc. | -28.51 Million USD | 871.605% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 351.03% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 1080.13% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | -97.263% |
| Axonics, Inc. | -26.05 Million USD | 944.303% |
| Outset Medical, Inc. | -169.77 Million USD | 229.587% |
| IRIDEX Corporation | -10 Million USD | 2298.461% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 301.521% |
| IRadimed Corporation | 20.03 Million USD | -998.053% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 2768.284% |
| INVO Bioscience, Inc. | -6.76 Million USD | 3350.997% |
| Telesis Bio, Inc. | -35.15 Million USD | 725.889% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -1435.241% |
| Varex Imaging Corporation | 32.1 Million USD | -585.358% |
| Quipt Home Medical Corp. | 3.91 Million USD | -5513.677% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 1913.237% |
| Pulmonx Corporation | -61.93 Million USD | 455.211% |
| Dynatronics Corporation | -2.27 Million USD | 9778.634% |
| Modular Medical, Inc. | -17.52 Million USD | 1355.063% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 1602.835% |
| Semler Scientific, Inc. | 22.25 Million USD | -888.497% |
| InMode Ltd. | 195.66 Million USD | -12.44% |
| Bruker Corporation | 436.9 Million USD | 49.645% |
| Cytosorbents Corporation | -31.2 Million USD | 804.919% |
| DexCom, Inc. | 597.7 Million USD | 63.192% |
| Align Technology, Inc. | 643.33 Million USD | 65.803% |
| Viveve Medical, Inc. | -21.55 Million USD | 1120.74% |
| ZimVie Inc. | -30.93 Million USD | 811.077% |
| Movano Inc. | -29.69 Million USD | 840.99% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 890.088% |
| Nexalin Technology, Inc. | -5.69 Million USD | 3962.159% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 6335.828% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 194.327% |
| Profound Medical Corp. | -28.61 Million USD | 868.801% |
| enVVeno Medical Corporation | -25.23 Million USD | 971.701% |
| Surmodics, Inc. | -5.64 Million USD | 3997.254% |
| iCAD, Inc. | -7.68 Million USD | 2961.23% |
| Nuwellis, Inc. | -17.63 Million USD | 1347.873% |
| Biotricity, Inc. | -8.82 Million USD | 2591.995% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 275.774% |
| Aethlon Medical, Inc. | -12.63 Million USD | 1840.979% |
| InspireMD, Inc. | -21.14 Million USD | 1140.534% |
| PAVmed Inc. | -68.79 Million USD | 419.791% |
| BIOLASE, Inc. | -17.93 Million USD | 1326.515% |
| Beyond Air, Inc. | -63 Million USD | 449.173% |
| FONAR Corporation | 16.53 Million USD | -1230.482% |
| AxoGen, Inc. | -21.46 Million USD | 1125.068% |
| Vivani Medical, Inc. | -26.96 Million USD | 915.872% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -1119.445% |
| Inari Medical, Inc. | -14.03 Million USD | 1667.845% |
| UFP Technologies, Inc. | 57.66 Million USD | -281.521% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 4564.648% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 3588.868% |
| Tenon Medical, Inc. | -15.72 Million USD | 1498.868% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 3043.538% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 615.147% |
| AdaptHealth Corp. | -598.4 Million USD | 136.765% |
| Sintx Technologies, Inc. | -13.35 Million USD | 1746.953% |
| NanoVibronix, Inc. | -3.43 Million USD | 6502.794% |
| Quanterix Corporation | -49.7 Million USD | 542.647% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 1913.237% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 57691.623% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 165.776% |
| TransMedics Group, Inc. | -28.72 Million USD | 865.83% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 1031.73% |
| NeuroMetrix, Inc. | -7.15 Million USD | 3176.269% |
| Hyperfine, Inc. | -48.11 Million USD | 557.238% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 438.326% |
| Biomerica, Inc. | -6.36 Million USD | 3555.316% |
| Bone Biologics Corporation | -9.42 Million USD | 2433.4% |
| AVITA Medical, Inc. | -40.4 Million USD | 644.526% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 2233.599% |
| Silk Road Medical, Inc | -59.27 Million USD | 471.176% |